Phase III Study of OT202 in Treating Moderate to Severe Dry Eye
Clinical trial NCT07740564 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07740564
- Sponsor
- Ocumension Therapeutics (Suzhou) Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2029-01-01
- Enrollment
- 842
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.